We use cookies for a better user experience. Read our Privacy Policy

I Agree

Sepsis Treatment Market

Sepsis Treatment Market (Type: Severe Sepsis, Septic Shock, and Sepsis in Need of Blood Purification; Therapy: Continuous Renal Replacement Therapies [CRRT], Intermittent Hemodialysis, Sustained Low-efficiency Daily Dialysis [SLEDD], and Others; and End User: Hospitals, Specialty Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Can COVID-19 Pneumonia Lead to Severe Septic Shock in Patients?

The Global Sepsis Alliance has stated that the novel coronavirus may lead to sepsis by affecting the body’s immune system response toward the infection, resulting in organ damage and even death. Such developments are creating revenue opportunities for stakeholders in the sepsis treatment market. COVID-19 pneumonia is one of the major factors to cause sepsis in patients, owing to severe lung inflammation that occurs in response to the novel infection.

Bacterial, fungal, and viral infections have the possibility to cause coronavirus pneumonia, thus leading to sepsis. It has been found that patients with severe COVID-19 from Seattle reported severe septic shock, which triggered the demand for drugs to support heart and blood circulation. This has compelled companies in the sepsis treatment market to ensure the availability of treatments and medical supplies to improve patient quality of life.

To know the scope of our report Get a Sample on Sepsis Treatment Market

Severity of AKI, Presence of Electrolyte Disorders Influence Outcomes after CRRT

Continuous Renal Replacement Therapy (CRRT) is considered as the gold standard for sepsis syndromes. However, complications of CRRT such as risks associated with intravascular lines such as hemorrhage, infection or thrombosis need to be communicated to the patient or the family, while considering initiation. Stakeholders in the sepsis treatment market are working closely with healthcare professionals to troubleshoot problems of CRRT by considering factors including severity of illness and necessity of the procedure to reduce morbidity and mortality rates.

CRRT is linked with electrolyte disturbances and hypothermia in patients. Hence, clinicians are considering various factors such as judging the severity of acute kidney injury (AKI) and the presence of electrolyte or acid-base disorders to improve medical outcomes.

Get a glimpse of the in-depth analysis through our Report Brochure

Heparin-free RRT Anticoagulation Strategy Decreases Risk of Bleeding in Patients

The global sepsis treatment market is expected to reach US$ 1.6 Bn by the end of 2031. The high number of sepsis patients in the U.S. is creating stable revenue streams for stakeholders. Though CRRT dominates most sepsis procedures in intensive care units (ICUs), there is a significant demand for intermittent hemodialysis (IHD) for the treatment of patients.

Anticoagulation is required for renal replacement therapy (RRT) to prevent clotting of the extracorporeal circuit. On the other hand, systematic heparin anticoagulation is commonly used during IHD. However, this procedure increases the risk of bleeding and results in high ICU mortality rates. In order to overcome this issue, companies in the sepsis treatment market are offering heparin-free RRT anticoagulation strategy for patients.

Companies to Collaborate with Researchers to Advance in Sepsis Diagnosis

The European Sepsis Academy (ESA-ITN) is gaining recognition for advancements in sepsis diagnosis and treatment. This research project involves a training network that assists in diagnosis of sepsis through biomarker diagnostics and clinical trial models. Companies in the sepsis treatment market are taking cues from such research projects and collaborating with researchers to gain information on pathogenesis of sepsis-induced immune suppression and the development of diagnostic platforms.

Companies in the sepsis treatment market are increasing their research in identification and validation of diagnostic markers. They are gaining emphasis on regulatory mechanisms that drive inflammation and immunosuppression during sepsis.

ML-based Sepsis Detection, Management Platform Exhibit Potential to Improve Patient Outcomes

The sepsis deep learning technology is expected to bring a significant change in the global sepsis treatment market. This has led to the popularity of Sepsis Watch, which was developed in November 2018, and serves as a sepsis detection and management platform that can be used by clinicians to improve compliance with recommended treatment guidelines for sepsis. However, there is a need for new mechanisms of trust and accountability that must be developed to ensure that the systems are safe and reliable. Such platforms hold promising potentials to improve patient outcomes and create value grab opportunities for companies in the sepsis treatment market.

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

The COVID-19 pandemic has resulted in high mortality of patients who were previously and are currently diagnosed with sepsis. CRRT has the potential to prevent worsening of cerebral edema in patients. However, CRRT is associated with electrolyte disturbances and hypotention. Hence, stakeholders in the sepsis treatment market should increase awareness about the adoption of an inter-professional approach to provide safe and efficient CRRT in patients and reduce incidence of complications. Companies in the sepsis treatment market are increasing efforts to learn the health system framework and previously described best practices for bringing in routine and responsible machine learning (ML) in healthcare. They should collaborate with researchers to prevent post-sepsis sequelae and post-sepsis pathways to optimize treatment.

Sepsis Treatment Market: Overview

  • The global sepsis treatment market was valued over US$ 600 Mn in 2020 and is projected to expand at a moderate CAGR from 2021 to 2031. Growth of the sepsis treatment market can be attributed to increase in patient population with infectious diseases such as COVID-19 and acute kidney injury; rise in investment by pharmaceutical and biotechnology companies in drug discovery; and surge in launch of new products for the treatment of sepsis.
  • Presence of key players with technologically advanced products and strong geographic presence are anticipated to propel the global sepsis treatment market. Key industry events, including partnerships, mergers & acquisitions, and collaborations, are expected to fuel the growth of the global sepsis treatment market.
  • According to United Nations University (UNU) estimates, the percentage of the world population above 65 years of age is anticipated to increase from 9% in 2010 to 16% by 2050. Hence, increase in the population above 65 years of age asserts the need of safe and effective therapeutics for sepsis treatment. Therefore, rise in population of this group is a major driver of the market.
  • Increase in number of product launches and collaborations among players is a major factor propelling of the global sepsis treatment market
  • Large number of drugs are under different phases of clinical trials for the treatment of sepsis. Leading companies have made significant investments in clinical R&D and have established strategic partnerships and collaborations to accelerate new product development.
  • Asahi Kasei Corporation’s ART-123 is currently in phase III clinical trial and is expected to launch in the first half of 2021
  • Altor BioScience is developing anti-TF antibody (ALT-836) to treat septic patients with acute lung injury or acute respiratory distress syndrome

Sepsis Treatment Market: Segmentation

  • The global sepsis treatment market has been segmented based on type, therapy, end user, and region
  • In terms of type, the global sepsis treatment market has been classified into severe sepsis, septic shock, and sepsis in need of blood purification. The severe sepsis segment accounted for significant share of the global market in 2020. The segment's dominance can be attributed to increase in patient population with infectious diseases such as COVID-19. According to the Global Sepsis Alliance, signs of multi-organ injury, typical of severe sepsis, occur in 2% to 5% of patients with COVID-19 after eight to 10 days.
  • Based on therapy, the global sepsis treatment market has been categorized into continuous renal replacement therapies (CRRT), intermittent hemodialysis, sustained low-efficiency daily dialysis (SLEDD), and others. The continuous renal replacement therapies (CRRT) segment dominated the global sepsis treatment market in 2020. Increase in demand for CRRT devices for acute dialysis and various strategic decisions taken by various firms to increase CRRT production are expected to drive the segment during the forecast period. For instance, Baxter has taken a strategic decision to maximize its supply of CRRT devices, fluids, and sets to counter the unprecedented increase in demand for its acute dialysis products in Europe and the U.S.
  • In terms of end user, the global sepsis treatment market has been divided into hospitals, specialty centers, and others. The hospitals segment accounted for major share of the market in 2020. Hospitals are an important channel for sepsis treatment. According to government healthcare facilities, hospitals have reimbursement plans and advanced technology systems for sepsis treatment. Growth of the segment can be attributed to an increase in number of hospital facilities across the world.

Sepsis Treatment Market: Regional Segmentation

  • In terms of region, the global sepsis treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America is projected to be a highly attractive market during the forecast period. Well-established healthcare and life science industries, early adoption of technologically advanced products, high awareness about various infectious as well as chronic diseases, and high per capita healthcare expenditure are the major factors attributed to North America’s large market share in 2020.
  • The sepsis treatment market in Asia Pacific is anticipated to grow at a rapid pace during the forecast period. Increase in disposable income & purchasing power of consumers, rise in biotechnology, research institutes, and research funding by government & private bodies, expansion of healthcare infrastructure, large population base, and increase in incidence of sepsis related disorders are expected to augment the sepsis treatment market in Asia Pacific during the forecast period. Economic growth of China, India, Indonesia, and other countries in Southeast Asia is likely to increase healthcare expenditure, which is projected to drive the sepsis treatment market in the region.

Sepsis Treatment Market: Major Players

  • Key players operating in the global sepsis treatment market include
    • Baxter International, Inc.
    • Fresenius Medical Care AG & Co. KGaA
    • Nipro Corporation
    • Asahi Kasei
    • B. Braun Group
    • CytoSorbents Corporation
    • Medtronic plc
    • Nikkiso Co., Ltd.
    • Medica SPA
    • Toray Industries
    • Merck & Co., Inc.
  • These players focus on adopting various strategies to expand product offerings and to strengthen geographic presence across the globe. Technological advancements, mergers & acquisitions, expansion of product portfolio, and increase in research & development activities are the strategies adopted by the companies to expand business in the global sepsis treatment market.

Sepsis Treatment Market – Segmentation

Type
  • Severe Sepsis
  • Sepsis Shock
  • Sepsis in Need of Blood Purification
Therapy
  • Continuous Renal Replacement Therapies (CRRT)
  • Intermittent Hemodialysis
  • Sustained Low-efficiency Daily Dialysis (SLEDD)
  • Others
End User
  • Hospitals
  • Specialty Centers
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Sepsis Treatment Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of sepsis treatment market?

Sepsis treatment market was valued over US$ 600 Mn in 2020 and is expected to reach US$ 1.6 Bn by the end of 2031

What are the key driving factors for the growth of the sepsis treatment market?

Sepsis treatment market is driven by increase in number of product launches and collaborations among players

Which is the rising prominent segment in the sepsis treatment market?

The severe sepsis segment accounted for significant share of the global sepsis treatment market, the segment's dominance can be attributed to increase in patient population with infectious diseases such as COVID-19

What are the end-use segments in the sepsis treatment market?

The hospitals segment accounted for major share of the sepsis treatment market, hospitals are an important channel for sepsis treatment

Who are the key players in the global sepsis treatment market?

Key players in the global sepsis treatment market include Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, Nipro Corporation, Asahi Kasei, B. Braun Group, CytoSorbents Corporation

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Sepsis Treatment Market

4. Market Overview

    4.1. Introduction

        4.1.1. Market Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Sepsis Treatment Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Sepsis Population (admissions as % of population)

    5.2. Total Sepsis Hospital Admissions [general ward & other, ICU patients admitted (000)]

    5.3. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)

    5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Sepsis Treatment Market Analysis and Forecast, by Type 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Global Sepsis Treatment Market Value (US$ Bn) Forecast, by Type, 2017–2031

        6.3.1. Severe Sepsis

        6.3.2. Septic Shock

        6.3.3. Sepsis in Need of Blood Purification

    6.4. Global Sepsis Treatment Market Attractiveness Analysis, by Type

7. Global Sepsis Treatment Market Analysis and Forecast, by Therapy 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

        7.3.1. Continuous Renal Replacement Therapies (CRRT)

        7.3.2. Intermittent Hemodialysis

        7.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)

        7.3.4. Others

    7.4. Global Sepsis Treatment Market Attractiveness Analysis, by Therapy 

8. Global Sepsis Treatment Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Global Sepsis Treatment Market Value (US$ Bn) Forecast, by End-user, 2017–2031

        8.3.1. Hospitals

        8.3.2. Specialty Centers

        8.3.3. Others

    8.4. Global Sepsis Treatment Market Attractiveness Analysis, by End-user 

9. Global Sepsis Treatment Market Analysis and Forecast, by Region 

    9.1. Key Findings

    9.2. Global Sepsis Treatment Market Value (US$ Bn) Forecast, by Region

        9.2.1. North America

        9.2.2. Europe 

        9.2.3. Asia Pacific

        9.2.4. Latin America 

        9.2.5. Middle East & Africa

    9.3. Global Sepsis Treatment Market Attractiveness Analysis, by Region

10. North America Sepsis Treatment Market Analysis and Forecast

    10.1.  Introduction

        10.1.1.  Key Findings

    10.2. North America Sepsis Treatment Market Value (US$ Bn) Forecast, by Type , 2017–2031

        10.2.1. Severe Sepsis

        10.2.2. Septic Shock

        10.2.3. Sepsis in Need of Blood Purification

    10.3. North America Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

        10.3.1. Continuous Renal Replacement Therapies (CRRT)

        10.3.2. Intermittent Hemodialysis

        10.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)

        10.3.4. Others

    10.4. North America Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

        10.4.1. Hospitals

        10.4.2. Specialty Centers

        10.4.3. Others

    10.5. North America Sepsis Treatment Market Value (US$ Bn) Forecast, by Country, 2017–2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Sepsis Treatment Market Attractiveness Analysis

        10.6.1. By Type 

        10.6.2. By Therapy 

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Sepsis Treatment Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Europe Sepsis Treatment Market Value (US$ Bn) Forecast, by Type, 2017–2031

        11.2.1. Severe Sepsis

        11.2.2. Septic Shock

        11.2.3. Sepsis in Need of Blood Purification

    11.3. Europe Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

        11.3.1. Continuous Renal Replacement Therapies (CRRT)

        11.3.2. Intermittent Hemodialysis

        11.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)

        11.3.4. Others

    11.4. Europe Sepsis Treatment Market Value (US$ Bn) Forecast, by End-user, 2017–2031

        11.4.1. Hospitals

        11.4.2. Specialty Centers

        11.4.3. Others

    11.5. Europe Sepsis Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Europe Sepsis Treatment Market Attractiveness Analysis

        11.6.1. By Type 

        11.6.2. By Therapy 

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Sepsis Treatment Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Asia Pacific Sepsis Treatment Market Value (US$ Bn) Forecast, by Type, 2017–2031

        12.2.1. Severe Sepsis

        12.2.2. Septic Shock

        12.2.3. Sepsis in Need of Blood Purification

    12.3. Asia Pacific Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

        12.3.1. Continuous Renal Replacement Therapies (CRRT)

        12.3.2. Intermittent Hemodialysis

        12.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)

        12.3.4. Others

    12.4. Asia Pacific Sepsis Treatment Market Value (US$ Bn) Forecast, by End-user, 2017–2031

        12.4.1. Hospitals

        12.4.2. Specialty Centers

        12.4.3. Others

    12.5. Asia Pacific Sepsis Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031

        12.5.1. China

        12.5.2. Japan

        12.5.3. India 

        12.5.4. Australia & New Zealand 

        12.5.5. Rest of Asia Pacific

    12.6. Asia Pacific Sepsis Treatment Market Attractiveness Analysis

        12.6.1. By Type

        12.6.2. By Therapy 

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Sepsis Treatment Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Latin America Sepsis Treatment Market Value (US$ Bn) Forecast, by Type, 2017–2031

        13.2.1. Severe Sepsis

        13.2.2. Septic Shock

        13.2.3. Sepsis in Need of Blood Purification

    13.3. Latin America Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

        13.3.1. Continuous Renal Replacement Therapies (CRRT)

        13.3.2. Intermittent Hemodialysis

        13.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)

        13.3.4. Others

    13.4. Latin America Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

        13.4.1. Hospitals

        13.4.2. Specialty Centers

        13.4.3. Others

    13.5. Latin America Sepsis Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Sepsis Treatment Market Attractiveness Analysis

        13.6.1. By Type

        13.6.2. By Therapy

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Sepsis Treatment Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Middle East & Africa Sepsis Treatment Market Value (US$ Bn) Forecast, by Type, 2017–2031

        14.2.1. Severe Sepsis

        14.2.2. Septic Shock

        14.2.3. Sepsis in Need of Blood Purification

    14.3. Middle East & Africa Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

        14.3.1. Continuous Renal Replacement Therapies (CRRT)

        14.3.2. Intermittent Hemodialysis

        14.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)

        14.3.4. Others

    14.4. Middle East & Africa Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

        14.4.1. Hospitals

        14.4.2. Specialty Centers

        14.4.3. Others

    14.5. Middle East & Africa Sepsis Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031

        14.5.1. GCC Countries 

        14.5.2. South Africa 

        14.5.3. Rest of Middle East & Africa

    14.6. Middle East & Africa Sepsis Treatment Market Attractiveness Analysis

        14.6.1. By Type

        14.6.2. By Therapy 

        14.6.3. By End-user

        14.6.4. By Country/Sub-region

15. Competitive Landscape

    15.1. Market Player - Competition Matrix (by tier and size of companies)

    15.2.  Company Profiles

        15.2.1. Baxter International, Inc.

            15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.1.2. Financial Overview

            15.2.1.3. Product Portfolio

            15.2.1.4. Strategic Overview

            15.2.1.5. SWOT Analysis

        15.2.2. Fresenius Medical Care AG & Co. KGaA 

            15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.2.2. Financial Overview

            15.2.2.3. Product Portfolio

            15.2.2.4. Strategic Overview

            15.2.2.5. SWOT Analysis

        15.2.3. Nipro Corporation

            15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.3.2. Financial Overview

            15.2.3.3. Product Portfolio

            15.2.3.4. Strategic Overview

            15.2.3.5. SWOT Analysis

        15.2.4. Asahi Kasei 

            15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.4.2. Financial Overview

            15.2.4.3. Product Portfolio

            15.2.4.4. Strategic Overview

            15.2.4.5. SWOT Analysis

        15.2.5. B. Braun Group

            15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.5.2. Product Portfolio

            15.2.5.3. Strategic Overview

            15.2.5.4. SWOT Analysis

        15.2.6. CytoSorbents Corporation

            15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.6.2. Financial Overview

            15.2.6.3. Product Portfolio

            15.2.6.4. Strategic Overview

            15.2.6.5. SWOT Analysis

        15.2.7. Medtronic plc

            15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.7.2. Financial Overview

            15.2.7.3. Product Portfolio

            15.2.7.4. Strategic Overview

            15.2.7.5. SWOT Analysis

        15.2.8. Nikkiso Co., Ltd.

            15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.8.2. Financial Overview

            15.2.8.3. Product Portfolio

            15.2.8.4. Strategic Overview

            15.2.8.5. SWOT Analysis

        15.2.9. Medica SPA

            15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.9.2. Financial Overview

            15.2.9.3. Product Portfolio

            15.2.9.4. Strategic Overview

            15.2.9.5. SWOT Analysis

        15.2.10. Toray Industries

            15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.10.2. Financial Overview

            15.2.10.3. Product Portfolio

            15.2.10.4. Strategic Overview

            15.2.10.5. SWOT Analysis

        15.2.11. Merck & Co., Inc.

            15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.11.2. Financial Overview

            15.2.11.3. Product Portfolio

            15.2.11.4. Strategic Overview

            15.2.11.5. SWOT Analysis

List of Tables

Table 01: Global Sepsis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 02: Global Sepsis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017–2031

Table 03: Global Sepsis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global Sepsis Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Sepsis Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Sepsis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 07: North America Sepsis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017–2031

Table 08: North America Sepsis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Europe Sepsis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Sepsis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 11: Europe Sepsis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017–2031

Table 12: Europe Sepsis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Asia Pacific Sepsis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Sepsis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 15: Asia Pacific Sepsis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017–2031

Table 16: Asia Pacific Sepsis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Latin America Sepsis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Latin America Sepsis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 19: Latin America Sepsis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017–2031

Table 20: Latin America Sepsis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Middle East & Africa Sepsis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Middle East & Africa Sepsis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 23: Middle East & Africa Sepsis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017–2031

Table 24: Middle East & Africa Sepsis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031 

List of Figures

Figure 01: Global Sepsis Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Sepsis Treatment Market Value Share, by Type, 2020

Figure 03: Global Sepsis Treatment Market Value Share, by Therapy, 2020

Figure 04: Global Sepsis Treatment Market Value Share, by End-user, 2020

Figure 05: Global Sepsis Treatment Market Value Share, by Region, 2020

Figure 06: Global Sepsis Treatment Market Value Share Analysis, by Type, 2020 and 2031

Figure 07: Global Sepsis Treatment Market Attractiveness Analysis, by Type, 2021–2031

Figure 08: Global Sepsis Treatment Market Revenue (US$ Mn), by Severe Sepsis/Sepsis, 2017–2031

Figure 09: Global Sepsis Treatment Market Revenue (US$ Mn), by Septic Shock, 2017–2031

Figure 10: Global Sepsis Treatment Market Revenue (US$ Mn), by Sepsis in Need of Blood Purification, 2017–2031

Figure 11: Global Sepsis Treatment Market Value Share Analysis, by Therapy, 2020 and 2031

Figure 12: Global Sepsis Treatment Market Attractiveness Analysis, by Therapy, 2021–2031

Figure 13: Global Sepsis Treatment Market Revenue (US$ Mn), by Continuous Renal Replacement Therapies (CRRT), 2017–2031

Figure 14: Global Sepsis Treatment Market Revenue (US$ Mn), by Intermittent Hemodialysis, 2017–2031

Figure 15: Global Sepsis Treatment Market Revenue (US$ Mn), by Sustained Low-efficiency Daily Dialysis (SLEDD), 2017–2031

Figure 16: Global Sepsis Treatment Market Revenue (US$ Mn), by Others, 2017–2031

Figure 17: Global Sepsis Treatment Market Value Share Analysis, by End-user, 2020 and 2031

Figure 18: Global Sepsis Treatment Market Attractiveness Analysis, by End-user, 2021–2031

Figure 19: Global Sepsis Treatment Market Revenue (US$ Mn), by Hospitals, 2017–2031

Figure 20: Global Sepsis Treatment Market Revenue (US$ Mn), by Specialty Centers, 2017–2031

Figure 21: Global Sepsis Treatment Market Revenue (US$ Mn), by Others, 2017–2031

Figure 22: Global Sepsis Treatment Market Value Share Analysis, by Region, 2020 and 2031

Figure 23: Global Sepsis Treatment Market Attractiveness Analysis, by Region, 2021–2031

Figure 24: North America Sepsis Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 25: North America Sepsis Treatment Market Value Share Analysis, by Country, 2020 and 2031

Figure 26: North America Sepsis Treatment Market Attractiveness Analysis, by Country, 2021–2031

Figure 27: North America Sepsis Treatment Market Value Share Analysis, by Type, 2020 and 2031

Figure 28: North America Sepsis Treatment Market Attractiveness Analysis, by Type, 2021–2031

Figure 29: North America Sepsis Treatment Market Value Share Analysis, by Therapy, 2020 and 2031

Figure 30: North America Sepsis Treatment Market Attractiveness Analysis, by Therapy, 2021–2031

Figure 31: North America Sepsis Treatment Market Value Share Analysis, by End-user, 2020 and 2031

Figure 32: North America Sepsis Treatment Market Attractiveness Analysis, by End-user, 2021–2031

Figure 33: Europe Sepsis Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 34: Europe Sepsis Treatment Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 35: Europe Sepsis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 36: Europe Sepsis Treatment Market Value Share Analysis, by Type, 2020 and 2031

Figure 37: Europe Sepsis Treatment Market Attractiveness Analysis, by Type, 2021–2031

Figure 38: Europe Sepsis Treatment Market Value Share Analysis, by Therapy, 2020 and 2031

Figure 39: Europe Sepsis Treatment Market Attractiveness Analysis, by Therapy, 2021–2031

Figure 40: Europe Sepsis Treatment Market Value Share Analysis, by End-user, 2020 and 2031

Figure 41: Europe Sepsis Treatment Market Attractiveness Analysis, by End-user, 2021–2031

Figure 42: Asia Pacific Sepsis Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 43: Asia Pacific Sepsis Treatment Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 44: Asia Pacific Sepsis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 45: Asia Pacific Sepsis Treatment Market Value Share Analysis, by Type, 2020 and 2031

Figure 46: Asia Pacific Sepsis Treatment Market Attractiveness Analysis, by Type, 2021–2031

Figure 47: Asia Pacific Sepsis Treatment Market Value Share Analysis, by Therapy, 2020 and 2031

Figure 48: Asia Pacific Sepsis Treatment Market Attractiveness Analysis, by Therapy, 2021–2031

Figure 49: Asia Pacific Sepsis Treatment Market Value Share Analysis, by End-user, 2020 and 2031

Figure 50: Asia Pacific Sepsis Treatment Market Attractiveness Analysis, by End-user, 2021–2031

Figure 51: Latin America Sepsis Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 52: Latin America Sepsis Treatment Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 53: Latin America Sepsis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 54: Latin America Sepsis Treatment Market Value Share Analysis, by Type, 2020 and 2031

Figure 55: Latin America Sepsis Treatment Market Attractiveness Analysis, by Type, 2021–2031

Figure 56: Latin America Sepsis Treatment Market Value Share Analysis, by Therapy, 2020 and 2031

Figure 57: Latin America Sepsis Treatment Market Attractiveness Analysis, by Therapy, 2021–2031

Figure 58: Latin America Sepsis Treatment Market Value Share Analysis, by End-user, 2020 and 2031

Figure 59: Latin America Sepsis Treatment Market Attractiveness Analysis, by End-user, 2021–2031

Figure 60: Middle East & Africa Sepsis Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 61: Middle East & Africa Sepsis Treatment Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 62: Middle East & Africa Sepsis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 63: Middle East & Africa Sepsis Treatment Market Value Share Analysis, by Type, 2020 and 2031

Figure 64: Middle East & Africa Sepsis Treatment Market Attractiveness Analysis, by Type, 2021–2031

Figure 65: Middle East & Africa Sepsis Treatment Market Value Share Analysis, by Therapy, 2020 and 2031

Figure 66: Middle East & Africa Sepsis Treatment Market Attractiveness Analysis, by Therapy, 2021–2031

Figure 67: Middle East & Africa Sepsis Treatment Market Value Share Analysis, by End-user, 2020 and 2031

Figure 68: Middle East & Africa Sepsis Treatment Market Attractiveness Analysis, by End-user, 2021–2031

Figure 69: Global Sepsis Treatment Market Share, by Company, 2019

Figure 70: Baxter International, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2019

Figure 71: Fresenius Medical Care AG & Co. KGaA Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2019

Figure 72: Nipro Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2019

Figure 73: Asahi Kasei Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2019

Figure 74: B. Braun Group Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2019

Figure 75: CytoSorbents Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2019

Figure 76: Medtronic Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Figure 77: NIKKISO CO., LTD Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Figure 78: Toray Industries Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Figure 79: Merck & Co. Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

623

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved